Discriminative-stimulus effects of triazolam in light and moderate drinkers

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 4, 2003, Pages 638-646

  Rush, Craig R ^a,b   Kelly, Thomas H ^a   Fillmore, Mark T ^b   Hays, Lon R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alcohol; Benzodiazepines; Drug discrimination; Individual differences; Triazolam

Indexed keywords

BENZODIAZEPINE; TRIAZOLAM;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DISCRIMINATION LEARNING; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; TASK PERFORMANCE;

EID: 0037393859     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000062742.29158.6E     Document Type: Article

References (36)

1. Abreu ME, Griffiths RR (1996) Drug tasting may confound human drug discrimination studies. Psychopharmacology 125:255-257.
2. Chilcoat HD, Johanson CE (1998) Vulnerability to cocaine abuse, in Cocaine Abuse Research: Pharmacology, Behavior and Clinical Applications (Higgins ST, Katz JL eds), pp 313-342. Academic Press, San Diego.
3. Ciraulo DA, Barnhill JG, Greenblatt DJ, Shader RI, Ciraulo AM, Tarmey MF, Molloy MA, Foti ME (1988a) Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry 49:333-337.
4. Ciraulo DA, Sands BF, Shader RI (1988b) Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry 145:1501-1506.
5. de Wit H, Doty P (1994) Preference for ethanol and diazepam in light and moderate social drinkers: a within-subjects study. Psychopharmacology 115:529-538.
6. de Wit H, Pierri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers. Pharmacol Biochem Behav 33:205-213.
7. Duka T, Jackson A, Smith DC, Stephens DN (1999) Relationship of components of an alcohol interoceptive stimulus to induction of desire for alcohol in social drinkers. Pharmacol Biochem Behav 64:301-309.
8. Evans S, Funderburk F, Griffiths RR (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 255:1246-1255.
9. Evans SM, Griffiths RR, de Wit H (1996) Preference for diazepam, but not buspirone, in moderate drinkers. Psychopharmacology 123:154-163.
10. Falk JL, Tang M (1989a) Schedule induction of drug intake: differential responsiveness to agents with abuse potential. J Pharmacol Exp Ther 249:143-148.
11. Falk JL, Tang M (1989b) Schedule-induced chlordiazepoxide intake: differential effect of cocaine and ethanol histories. Pharmacol Biochem Behav 33:393-396.
12. Fillmore MT, Mulvihill LE, Vogel-Sprott M (1994) The expected drug and its expected effect interact to determine placebo responses to alcohol and caffeine. Psychopharmacology 115:383-388.
13. Fillmore MT, Vogel-Sprott M (1996) Evidence that expectancies mediate behavioral impairment under alcohol. J Stud Alcohol 57:598-603.
14. Griffiths RR, Bigelow GE, Liebson I (1983) Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry 40:865-873.
15. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC (1973) Quantification of sleepiness: a new approach. Psychophysiology 10:431-436.
16. Jaffe J, Ciraulo D, Niles A, Monroe L (1983) Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal. Clin Pharmacol Ther 34:623-630.
17. Jasinski D (1977) Assessment of the abuse potentiality of morphine-like drugs (methods used in man), in Drug Addiction I (Marin WR ed), pp 197-258. Springer-Verlag, New York.
18. Kandel D, Yamaguchi K (1993) From beer to crack: developmental patterns of drug involvement. Am J Public Health 83:851-855.
19. Kollins SH, Rush CR (1999) Studying the relationship between the discriminative-stimulus and subject-rated effects of commonly abused stimulants: effects of training dose. Pharmacol Biochem Behav 64:319-326.
20. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258.
21. McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 14:463-466.
22. Mumford GK, Rush CR, Griffiths RR (1995a) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570-580.
23. Mumford GK, Rush CR, Griffiths RR (1995b) A comparison of the abuse liability of alprazolam and DN-2327 (pazinaclone) in humans: psychomotor, memory, subjective and reinforcing effects. Exp Clin Psychopharmacol 3:39-48.
24. Pagliaro L, Pagliaro AM (1993) The phenomenon of abusable psychotropic use among North American youth. J Clin Pharmacol 33:676-690.
25. Physician's Desk Reference (2000) Medical Economics Company, Inc, Oradell, NJ.
26. Rush CR, Ali JA (1999) A follow-up study of the acute behavioral effects of benzodiazepine-receptor ligands in humans: comparison of quazepam and triazolam. Exp Clin Psychopharmacol 7:257-265.
27. Rush CR, Armstrong DL, Ali JA, Pazzaglia PJ (1998) Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects. J Clin Psychopharmacol 18:154-166.
28. Rush CR, Baker RW (2001) Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task. Hum Psychopharmacol 16:147-157.
29. Rush CR, Baker RW, Rowlett JK (2000) Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital and caffeine in zolpidem-trained humans. Exp Clin Psychopharmacol 8:22-36.
30. Rush CR, Critchfield TS, Troisi JR II, Griffiths RR (1995) Discriminative stimulus effects of diazepam and buspirone in normal volunteers. J Exp Anal Behav 63:277-294.
31. Rush CR, Griffiths RR (1996) Zolpidem, triazolam and temazepam: behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol 16:146-157.
32. Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK (1997a) Discriminative-stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. J Pharmacol Exp Ther 280:174-188.
33. Rush CR, Madakasira S, Hayes CA, Johnson CA, Goldman NH, Pazzaglia PJ (1997b) Trazodone and triazolam: acute subject-rated and performance-impairing effects in healthy volunteers. Psychopharmacology 131:9-18.
34. Saladin ME, Brady KT, Dansky BS, Kilpatrick DG (1995) Understanding comorbidity between PTSD and substance abuse disorders: two preliminary investigations. Addict Behav 20:643-655.
35. Simpson CA, Rush CR (2002) Acute performance-impairing and subject-rated effects of triazolam and temazepam, alone and in combination with ethanol, in humans. J Psychopharmacol 16:23-34.
36. Substance Abuse and Mental Health Services Administration (1999) Summary of findings from the 1998 National Household Survey on Drug Abuse. Available at: http://www.samhsa.gov/OAS/NHSDA/98Sum-mHtml/TOC.htm.